Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-miR-320c: Hsa-mir-320c is a microRNA that has been found to be upregulated in plasma extracellular vesicles (EVs) in patients with progressive disease (PD) compared to those with partial response (PR) [PMC8121992]. The levels of hsa-mir-320c, along with hsa-miR-320d and hsa-miR-320b, were significantly higher in the PD group, indicating an unfavorable response of these microRNAs to immunotherapy [PMC8121992]. In a study using a cut-off at logCPM>4, p<0.05, and FDR≤0.1, hsa-miR-320d was identified as the most significant differentially expressed (DE) microRNA. Hsa-mir-320c was also found to be differentially expressed along with hsa-miR-642a-3p and hsa-miR-320b, with FDR values around 0.1 [PMC7057418]. These findings suggest that hsa-mir-320c may play a role in disease progression and could potentially serve as a biomarker for monitoring response to immunotherapy [PMC8121992][PMC7057418]. Further research is needed to fully understand the functional significance of hsa-mir-320c and its potential implications in PD and immunotherapy response.
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Localisation
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset